Aviva’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-185,309
Closed -$14.9M 772
2016
Q4
$14.9M Buy
185,309
+10,167
+6% +$807K 0.09% 248
2016
Q3
$14M Buy
175,142
+3,862
+2% +$312K 0.09% 266
2016
Q2
$13.4M Buy
171,280
+12,703
+8% +$906K 0.09% 256
2016
Q1
$8.72M Buy
158,577
+3,301
+2% +$180K 0.06% 330
2015
Q4
$9.59M Sell
155,276
-1,346
-0.9% -$84.9K 0.07% 293
2015
Q3
$9.88M Sell
156,622
-31,168
-17% -$2.22M 0.08% 272
2015
Q2
$13.7M Buy
187,790
+7,630
+4% +$551K 0.1% 231
2015
Q1
$11.8M Buy
180,160
+12,127
+7% +$806K 0.08% 284
2014
Q4
$10.9M Buy
168,033
+1,863
+1% +$120K 0.08% 266
2014
Q3
$9.99M Sell
166,170
-199
-0.1% -$13K 0.08% 279
2014
Q2
$11.5M Sell
166,369
-873
-0.5% -$56.6K 0.09% 259
2014
Q1
$10.9M Sell
167,242
-9,329
-5% -$607K 0.09% 248
2013
Q4
$10.9M Sell
176,571
-55,135
-24% -$3.19M 0.09% 247
2013
Q3
$12.4M Sell
231,706
-46,887
-17% -$2.41M 0.11% 222
2013
Q2
$12.7M Buy
+278,593
New +$12.1M 0.13% 196

Other funds holding STJ

Aviva's STJ Position: Q1 2017 in Review

Aviva sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 185,309 shares — an estimated $14.9M sold.

Aviva first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $14.9M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Aviva reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Aviva sold 185,309 St Jude Medical shares in Q1 2017, an estimated $14.9M.
  • Aviva first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Aviva's St Jude Medical position peaked at $14.9M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Aviva's 13F filing for Q1 2017, filed 15 May 2017.